2007

  1. Safety and Tolerability of Concurrent Natalizumab Treatment for Patients with Crohn’s Disease Not in Remission While Receiving Infliximab

  2. Probiotics in CD for postop recurrence

  3. Infliximab in paediatric CD

  4. Synbiotics in CD for postop recurrence

  5. Topical tacrolimus in perianal Crohn’s disease

  6. Two-Year Combination Antibiotic Therapy With Clarithromycin, Rifabutin, and Clofazimine for Crohn’s Disease

  7. Mesalazine high/low dose in UC